Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Ala-his-d-beta-nal-ala-trp-d-phe-lys-nh2
2. Alanyl-histidyl-(2-naphthyl)alanyl-tryptophyl-phenylalanyl-lysinamide
3. Ghrp-1
4. Kp 101
1. Ghrp-1
2. 39evi31p0w
3. 141925-59-9
4. Alanyl-histidyl-(2-naphthyl)alanyl-tryptophyl-phenylalanyl-lysinamide
5. (2s)-6-amino-2-[[(2r)-2-[[(2s)-2-[[(2s)-2-[[(2r)-2-[[(2s)-2-[[(2s)-2-aminopropanoyl]amino]-3-(1h-imidazol-5-yl)propanoyl]amino]-3-naphthalen-2-ylpropanoyl]amino]propanoyl]amino]-3-(1h-indol-3-yl)propanoyl]amino]-3-phenylpropanoyl]amino]hexanamide
6. Ghrp 1
7. Unii-39evi31p0w
8. Chembl427926
9. Kp 101
10. Ala-his-d-beta-nal-ala-trp-d-phe-lys-nh2
11. Q27256893
12. Ala-his-3-(2-naphthalenyl)-d-ala-ala-trp-d-phe-lys-nh2
13. L-alanyl-l-histidyl-3-(2-naphthalenyl)-d-alanyl-l-alanyl-l-tryptophyl-d-phenylalanyl-l-lysinamide
14. L-lysinamide, L-alanyl-l-histidyl-3-(2-naphthalenyl)-d-alanyl-l-alanyl-l-tryptophyl-d-phenylalanyl-
| Molecular Weight | 955.1 g/mol |
|---|---|
| Molecular Formula | C51H62N12O7 |
| XLogP3 | 2.8 |
| Hydrogen Bond Donor Count | 11 |
| Hydrogen Bond Acceptor Count | 10 |
| Rotatable Bond Count | 25 |
| Exact Mass | 954.48644236 g/mol |
| Monoisotopic Mass | 954.48644236 g/mol |
| Topological Polar Surface Area | 314 Ų |
| Heavy Atom Count | 70 |
| Formal Charge | 0 |
| Complexity | 1750 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 7 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
28
PharmaCompass offers a list of Growth hormone-releasing peptide 1 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Growth hormone-releasing peptide 1 manufacturer or Growth hormone-releasing peptide 1 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Growth hormone-releasing peptide 1 manufacturer or Growth hormone-releasing peptide 1 supplier.
PharmaCompass also assists you with knowing the Growth hormone-releasing peptide 1 API Price utilized in the formulation of products. Growth hormone-releasing peptide 1 API Price is not always fixed or binding as the Growth hormone-releasing peptide 1 Price is obtained through a variety of data sources. The Growth hormone-releasing peptide 1 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Growth hormone-releasing peptide 1 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Growth hormone-releasing peptide 1, including repackagers and relabelers. The FDA regulates Growth hormone-releasing peptide 1 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Growth hormone-releasing peptide 1 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Growth hormone-releasing peptide 1 supplier is an individual or a company that provides Growth hormone-releasing peptide 1 active pharmaceutical ingredient (API) or Growth hormone-releasing peptide 1 finished formulations upon request. The Growth hormone-releasing peptide 1 suppliers may include Growth hormone-releasing peptide 1 API manufacturers, exporters, distributors and traders.
Growth hormone-releasing peptide 1 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Growth hormone-releasing peptide 1 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Growth hormone-releasing peptide 1 GMP manufacturer or Growth hormone-releasing peptide 1 GMP API supplier for your needs.
A Growth hormone-releasing peptide 1 CoA (Certificate of Analysis) is a formal document that attests to Growth hormone-releasing peptide 1's compliance with Growth hormone-releasing peptide 1 specifications and serves as a tool for batch-level quality control.
Growth hormone-releasing peptide 1 CoA mostly includes findings from lab analyses of a specific batch. For each Growth hormone-releasing peptide 1 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Growth hormone-releasing peptide 1 may be tested according to a variety of international standards, such as European Pharmacopoeia (Growth hormone-releasing peptide 1 EP), Growth hormone-releasing peptide 1 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Growth hormone-releasing peptide 1 USP).
